| OEI73166.1 |
Bcr/CflA_family_drug_resistance_efflux_transporter |
BGC0002977.1 |
NRPS:Type I+PKS:Type I |
100.0 |
100.0 |
741.0 |
2.54e-272 |
| QIJ31525.1 |
Ctg1_35 |
BGC0002545.3 |
PKS |
37.0 |
91.8 |
230.0 |
1.72e-71 |
| WP_020636855.1 |
multidrug_effflux_MFS_transporter |
BGC0002011.3 |
PKS |
37.0 |
95.8 |
216.0 |
5.18e-66 |
| CDG76950.1 |
permease_of_the_major_facilitator_superfamily_protein |
BGC0000446.5 |
NRPS:Type I |
34.0 |
95.0 |
209.0 |
3.73e-63 |
| ATJ04402.1 |
MFS_transporter |
BGC0001637.3 |
NRPS:Type I |
34.0 |
95.0 |
207.0 |
1.45e-62 |
| AAM54113.1 |
bicyclomycin_resistant_protein |
BGC0000020.3 |
PKS |
31.0 |
59.7 |
99.0 |
1.78e-22 |
| CDG12868.1 |
putative_drug_efflux_protein |
BGC0001415.4 |
NRPS:Type I+PKS |
26.0 |
98.0 |
97.0 |
6.55e-22 |
| CCA29199.1 |
hypothetical_protein |
BGC0000955.5 |
NRPS:Type I+PKS:Type I |
28.0 |
63.2 |
95.0 |
7.77e-21 |
| QBK15054.1 |
major_facilitator_TraF |
BGC0003028.1 |
NRPS:Type I+PKS:Type II highly reducing |
26.0 |
39.6 |
61.0 |
8.56e-10 |